Prescription drug advertising is facing renewed scrutiny from the FDA and bipartisan lawmakers, Axios reports

Newsquawk StaffPublished
Newsquawk headlinesUTC

Every headline is on the live feed 20 minutes before this site.

India has set 21st May as the final hearing date in Apple (AAPL) antitrust case, according to a regulatory order

Dutch Government reportedly allocates EUR 950mln for energy price compensation

Prescription drug advertising is facing renewed scrutiny from the FDA and bipartisan lawmakers, Axios reports

Iran is reviewing the US proposal delivered via Pakistan, ISNA reports

Novo Nordisk (NOVOB DC) announces that Etavopivat met its primary endpoints in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis events and improving haemoglobin response in sickle cell disease

On the Newsquawk feed at , 20 minutes before this page.

Use the PlatformFree. No signup, no card.
  • The FDA says many ads and social media posts fail fair-balance standards, though tougher rules could face industry resistance and First Amendment challenges
  • Proposals range from tighter enforcement and pre-screening, to tax penalties or an outright ban

Related headlines

The feed had this first.

Use the Platform